Middle East News Center: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Center.

Press releases published on September 10, 2026

Sep. 10, 2026

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

Indeterminate GlobeNewswire

Sep. 10, 2026

Vistagen to Present at Psych Congress 2026

Indeterminate GlobeNewswire

Sep. 10, 2026

HUB Announces Reverse Share Split

Indeterminate GlobeNewswire

Sep. 10, 2026

Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer

Indeterminate GlobeNewswire

Sep. 10, 2026

ORYZON to Participate in Upcoming Events in September and October

Indeterminate GlobeNewswire

Sep. 10, 2026

Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases

Indeterminate GlobeNewswire

Sep. 10, 2026

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Indeterminate GlobeNewswire

Sep. 10, 2026

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

Indeterminate GlobeNewswire

Sep. 10, 2026

SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 10, 2026

Novacium and Tokai COBEX Collaborate to Evaluate an Integrated and Sovereign European Anode Material Solution for Lithium-Ion Batteries

Indeterminate GlobeNewswire

Sep. 10, 2026

Novacium et Tokai COBEX collaborent à l’évaluation d’une solution européenne intégrée et souveraine de matériaux d’anode pour batteries lithium-ion

Indeterminate GlobeNewswire

Sep. 10, 2026

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

Indeterminate GlobeNewswire

Sep. 10, 2026

TERRA CLEAN ENERGY CORP ANNOUNCES COMMENCEMENT OF TRENCHING AND DRILL PAD CONSTRUCTION AT THE MARYSVALE URANIUM MINES PROJECT

Indeterminate GlobeNewswire

Sep. 10, 2026

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

Indeterminate GlobeNewswire

Sep. 10, 2026

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader

Indeterminate GlobeNewswire

Sep. 10, 2026

Actithera significantly strengthens leadership team and Board as Company advances towards clinical development

Indeterminate GlobeNewswire

Sep. 10, 2026

Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program

Indeterminate GlobeNewswire

Sep. 10, 2026

Surge Copper’s Berg Project Selected for Canada Investment Summit Dealbook

Indeterminate GlobeNewswire

Sep. 10, 2026

Beamr Blueprint Takes AI Enhancement From Demo to Broadcast Production

Indeterminate GlobeNewswire